MYVAJRA Tablet is an antiviral medication used in the treatment of HIV-1 infection. It is typically prescribed as part of a combination antiretroviral therapy (ART) regimen to help reduce the viral load, improve immune function, and prevent the progression of HIV to AIDS. MYVAJRA contains two active ingredients that work synergistically to inhibit the replication of the HIV virus, thereby helping to manage the infection and maintain a healthier immune system.

Active Ingredients:

MYVAJRA Tablet contains the following active ingredients:

• Dolutegravir (DTG) – 50 mg
• An integrase strand transfer inhibitor (INSTI) that prevents the HIV virus from integrating its genetic material into the host cell’s DNA, a key step in the replication process.
• Lamivudine (3TC) – 300 mg
• A nucleoside reverse transcriptase inhibitor (NRTI) that blocks the action of reverse transcriptase, an enzyme needed for HIV replication.

Together, these ingredients help inhibit both the integration and replication processes of HIV, leading to a reduction in the viral load.

How Does MYVAJRA Tablet Work?

MYVAJRA Tablet works by targeting two critical stages of the HIV lifecycle:

1. Lamivudine (3TC) inhibits reverse transcriptase, preventing the virus from converting its RNA into DNA.
2. Dolutegravir (DTG) blocks the integrase enzyme, preventing the virus from integrating its DNA into the host cell’s genome.

This dual mechanism of action helps to effectively reduce the amount of virus in the body, improving the immune system’s ability to fight off infections.

Indications:

• Treatment of HIV-1 infection in adults and adolescents as part of a combination ART regimen.
• MYVAJRA is used to reduce viral load, improve immune function, and prevent the progression of HIV to AIDS.

Key Benefits:

• Effective in reducing viral load and improving immune system function.
• Dual-action formulation, combining two antiretroviral drugs, making treatment more convenient and efficient.
• Helps reduce the risk of complications related to HIV infection, including the development of AIDS.
• 
  

FAQs:

1. Can MYVAJRA Tablet cure HIV?

No, MYVAJRA Tablet does not cure HIV. It is used to control the virus, reduce viral load, and improve immune function, but lifelong treatment is necessary to manage HIV effectively.

2. Is MYVAJRA Tablet safe during pregnancy or breastfeeding?

On the off chance that you are pregnant, wanting to become pregnant, or breastfeeding, counsel your PCP prior to taking MYVAJRA.Your healthcare provider will weigh the potential risks and benefits and may adjust your treatment plan accordingly.

3. How long should I take MYVAJRA Tablet?

MYVAJRA Tablet is typically used as part of a lifelong treatment plan for managing HIV infection. Your healthcare provider will guide you on the duration of treatment based on your health and how well you are responding to the therapy.

4. Can I stop taking MYVAJRA Tablet if I feel better?

No, don't quit taking MYVAJRA without talking with your medical services supplier. Stopping the medication abruptly can cause the virus to replicate again, leading to a rise in viral load and potential resistance to the drug.

5. Can MYVAJRA Tablet interact with other medications?

Yes, MYVAJRA may interact with other medications, including prescription drugs, over-the-counter medications, and supplements. Inform your doctor about all the medications you are currently taking to avoid any potential interactions.

6. Can I drink alcohol while taking MYVAJRA Tablet?

It is advisable to limit alcohol consumption while taking MYVAJRA, as alcohol can increase the risk of side effects like dizziness or liver problems. Always consult your healthcare provider about alcohol use during treatment.